These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726 [TBL] [Abstract][Full Text] [Related]
7. Viral nanoparticles for in vivo tumor imaging. Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies. Shahgolzari M; Dianat-Moghadam H; Fiering S Semin Cancer Biol; 2022 Nov; 86(Pt 2):1076-1085. PubMed ID: 34375725 [TBL] [Abstract][Full Text] [Related]
9. Icosahedral plant viral nanoparticles - bioinspired synthesis of nanomaterials/nanostructures. Narayanan KB; Han SS Adv Colloid Interface Sci; 2017 Oct; 248():1-19. PubMed ID: 28916111 [TBL] [Abstract][Full Text] [Related]
10. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization. Brune KD; Leneghan DB; Brian IJ; Ishizuka AS; Bachmann MF; Draper SJ; Biswas S; Howarth M Sci Rep; 2016 Jan; 6():19234. PubMed ID: 26781591 [TBL] [Abstract][Full Text] [Related]
11. Plant molecular farming of virus-like nanoparticles as vaccines and reagents. Rybicki EP Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1587. PubMed ID: 31486296 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases. Tao P; Zhu J; Mahalingam M; Batra H; Rao VB Adv Drug Deliv Rev; 2019 May; 145():57-72. PubMed ID: 29981801 [TBL] [Abstract][Full Text] [Related]
13. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies. Shahgolzari M; Fiering S J Cancer Immunol (Wilmington); 2022; 4(1):22-29. PubMed ID: 35600219 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo toxicity evaluation of plant virus nanocarriers. Blandino A; Lico C; Baschieri S; Barberini L; Cirotto C; Blasi P; Santi L Colloids Surf B Biointerfaces; 2015 May; 129():130-6. PubMed ID: 25847457 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Vaccines Against Respiratory Viruses. Al-Halifa S; Gauthier L; Arpin D; Bourgault S; Archambault D Front Immunol; 2019; 10():22. PubMed ID: 30733717 [TBL] [Abstract][Full Text] [Related]
16. Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen. Diamos AG; Larios D; Brown L; Kilbourne J; Kim HS; Saxena D; Palmer KE; Mason HS Vaccine; 2019 Jan; 37(1):137-144. PubMed ID: 30459071 [TBL] [Abstract][Full Text] [Related]
17. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets. Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915 [TBL] [Abstract][Full Text] [Related]
18. Viral nanoparticles: Current advances in design and development. Arul SS; Balakrishnan B; Handanahal SS; Venkataraman S Biochimie; 2024 Apr; 219():33-50. PubMed ID: 37573018 [TBL] [Abstract][Full Text] [Related]
19. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Pineo CB; Hitzeroth II; Rybicki EP Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana. Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]